American Oriental Bioengineering Reports Record Quarterly Revenue and Earnings and Provides Guidance for Q4 2006
16th Nov 2006, 12:53 GMT
American Oriental Bioengineering Q3 2006 Highlights: Organic Revenue Growth of 63% during the Quarter Consolidated Gross Margins improve 3.5% versus last year to 66.9% Mgmt Expects Q4 Revenue in the range of $37 mln to $39 mln and at least $0.15 in EPS American Oriental Bioengineering announced financial results for Q3 ended 9/30/2006.
Latest news from Distribution/ Logistics News from StratCenter.com:
- Abiomed signs Japanese distribution deal
- Abiomed, Medix Japan in Distribution Pact
- Abiomed Announces 5-Year, $16+ mln Impella and AB5000 Distribution Agreement with Medix Japan
- Flu Vaccine Distributors Support Nat'l Influenza Vaccination Week
- Federal Court Hears Arguments Against Controversial DM&E Railroad Project
- Langer acquires Twincraft
- Cardinal Health Releases RFID Pilot Results
- Natrol Announces Q3 2006 Results
- Medical Services Receives Regulatory Approval in Saudi Arabia
- Interpharm Announces Record Revenues and Profits for the 3 Month Period Ended 9/30/2006